Eisler Capital (US)’s DexCom DXCM Stock Holding History

Eisler Capital (US)’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-44,720	Closed	-$5.07M	–	528
2024 Q2	$5.07M	Buy	+44,720	New	+$5.65M	0.09%	198

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Eisler Capital (US)'s DXCM Position: Q3 2024 in Review

Eisler Capital (US) sold out of DexCom (DXCM) in Q3 2024, closing a stake of 44,720 shares — an estimated $5.07M sold.

Eisler Capital (US) first reported a position in DXCM in Q2 2024 and held it in 1 quarter. The position peaked at $5.07M in Q2 2024. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Eisler Capital (US) reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
Eisler Capital (US) sold 44,720 DexCom shares in Q3 2024, an estimated $5.07M.
Eisler Capital (US) first reported a position in DexCom in Q2 2024 and held it in 1 quarter.
Eisler Capital (US)'s DexCom position peaked at $5.07M in Q2 2024.
890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.